Kaplan, Havva SayhanPalabiyik, OnurKeles, Omer FarukYener, ZabitÇiçek, Hacı Ahmet2025-05-102025-05-1020251306-696X1307-794510.14744/tjtes.2025.553382-s2.0-85218113927https://doi.org/10.14744/tjtes.2025.55338https://search.trdizin.gov.tr/en/yayin/detay/1354775/the-effects-of-dexmedetomidine-on-liver-injury-in-rats-with-experimental-sepsis-a-histopathological-and-immunohistochemical-studyBACKGROUND: In the rat sepsis model, the protective effect of dexmedetomidine (Dex) in sepsis-induced tissue injuries by reduc- ing inflammation is still unclear. Research is ongoing to determine whether Dex modulates sepsis-induced tissue injury. The aim of this experimental study was to investigate the effect of Dex on liver injury in sepsis rats histopathologically and immunohistochemically. METHODS: In this study, sepsis was induced in rats by a 10 ml/kg E. coli injection, and the protective efficacy of Dex against liver damage was investigated through histopathological and immunohistochemical findings by the intraperitoneal administration of 100 μg/ kg Dex. RESULTS: In our results, the most striking and basic morphological changes in the liver tissues of sepsis group rats were neutrophil leukocyte infiltrations in and around the vessels. In Dex-treated groups, neutrophil leukocyte infiltrations were more prominent, and marked dilatations were observed in the vessels. The fact that inflammatory reactions were more prominent in the Dex-treated groups was thought to be related to the increase in vascular permeability due to Dex's vasodilation effect. CONCLUSION: According to the histopathological and immunohistochemical findings obtained in the present study, we conclude that Dex did not alleviate sepsis-induced liver inflammation in a rat sepsis model.eninfo:eu-repo/semantics/openAccessDexmedetomidineE. ColiHistopathologyLiverRatSepsisArticle312Q3Q3112118399639131354775WOS:001422004400003